Literature DB >> 29372079

Deciphering the Role of the Barr Body in Malignancy: An insight into head and neck cancer.

Deepti Sharma1, George Koshy1, Shruti Gupta2, Bhushan Sharma1, Sonal Grover1.   

Abstract

X chromosome inactivation is the epitome of epigenetic regulation and long non-coding ribonucleic acid function. The differentiation status of cells has been ascribed to X chromosome activity, with two active X chromosomes generally only observed in undifferentiated or poorly differentiated cells. Recently, several studies have indicated that the reactivation of an inactive X chromosome or X chromosome multiplication correlates with the development of malignancy; however, this concept is still controversial. This review sought to shed light on the role of the X chromosome in cancer development. In particular, there is a need for further exploration of the expression patterns of X-linked genes in cancer cells, especially those in head and neck squamous cell carcinoma (HNSCC), in order to identify different prognostic subpopulations with distinct clinical implications. This article proposes a functional relationship between the loss of the Barr body and the disproportional expression of X-linked genes in HNSCC development.

Entities:  

Keywords:  Cancer; Cell Differentiation; Head And Neck; Lyonization; Sex Chromatin; Squamous Cell Carcinoma; X Chromosome; X-Linked Genes

Mesh:

Year:  2018        PMID: 29372079      PMCID: PMC5766293          DOI: 10.18295/squmj.2017.17.04.003

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  66 in total

1.  The role of MAGEA2 in head and neck cancer.

Authors:  Chad A Glazer; Ian M Smith; Sheetal Bhan; Wenyue Sun; Steven S Chang; Kavita M Pattani; William Westra; Zubair Khan; Joseph A Califano
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2011-03

Review 2.  Skewed X inactivation in healthy individuals and in different diseases.

Authors:  Karen Helene Ørstavik
Journal:  Acta Paediatr Suppl       Date:  2006-04

3.  Expression of genes from the human active and inactive X chromosomes.

Authors:  C J Brown; L Carrel; H F Willard
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

Review 4.  Expression and function of a large non-coding RNA gene XIST in human cancer.

Authors:  Sarah M Weakley; Hao Wang; Qizhi Yao; Changyi Chen
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

Review 5.  Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis.

Authors:  Zdenko Herceg; Pierre Hainaut
Journal:  Mol Oncol       Date:  2007-03-14       Impact factor: 6.603

6.  Brain expressed and X-linked (Bex) proteins are intrinsically disordered proteins (IDPs) and form new signaling hubs.

Authors:  Eva M Fernandez; María D Díaz-Ceso; Marçal Vilar
Journal:  PLoS One       Date:  2015-01-22       Impact factor: 3.240

7.  Simultaneous dual targeting of Par-4 and G6PD: a promising new approach in cancer therapy? Quintessence of a literature review on survival requirements of tumor cells.

Authors:  Ingeborg Elisabeth Cernaj
Journal:  Cancer Cell Int       Date:  2016-11-15       Impact factor: 5.722

Review 8.  Xist localization and function: new insights from multiple levels.

Authors:  Andrea Cerase; Greta Pintacuda; Anna Tattermusch; Philip Avner
Journal:  Genome Biol       Date:  2015-08-15       Impact factor: 13.583

9.  Decreased brain-expressed X-linked 4 (BEX4) expression promotes growth of oral squamous cell carcinoma.

Authors:  Wei Gao; John Zeng-Hong Li; Si-Qi Chen; Chiao-Yun Chu; Jimmy Yu-Wai Chan; Thian-Sze Wong
Journal:  J Exp Clin Cancer Res       Date:  2016-06-13

Review 10.  DDX3, a potential target for cancer treatment.

Authors:  Guus Martinus Bol; Min Xie; Venu Raman
Journal:  Mol Cancer       Date:  2015-11-05       Impact factor: 27.401

View more
  1 in total

1.  The role of sex genotype in paediatric CNS tumour incidence and survival.

Authors:  Wai Cheong Soon; Edward Goacher; Sandeep Solanki; Josie Hayes; Melpo Kapetanstrataki; Susan Picton; Paul Dominic Chumas; Ryan Koshy Mathew
Journal:  Childs Nerv Syst       Date:  2021-05-05       Impact factor: 1.475

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.